Literature DB >> 632141

Hypoxic cell sensitizers for radiotherapy.

G E Adams.   

Abstract

Mesh:

Substances:

Year:  1978        PMID: 632141     DOI: 10.1016/0360-3016(78)90129-3

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  11 in total

1.  Local recurrence in adenocarcinoma of the rectosigmoid colon after curative surgical resection.

Authors:  O F Taylor; E K Reddy; W R Jewell; J Thomas
Journal:  J Natl Med Assoc       Date:  1986-11       Impact factor: 1.798

2.  Dose-dependence and related studies on the pharmacokinetics of misonidazole and desmethylmisonidazole in mice.

Authors:  P Workman
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

3.  Enhancement of the radiation response of EMT-6 tumours by a copper octabromotetracarboranylphenylporphyrin.

Authors:  M Miura; G M Morris; J W Hopewell; P L Micca; M S Makar; M M Nawrocky; M W Renner
Journal:  Br J Radiol       Date:  2011-11-17       Impact factor: 3.039

4.  A phase I/II study of a hypoxic cell radiosensitizer KU-2285 in combination with intraoperative radiotherapy.

Authors:  Y Shibamoto; G Ohshio; R Hosotani; Y Nishimura; T Manabe; M Imamura; M Abe
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 5.  Advanced nanomaterials targeting hypoxia to enhance radiotherapy.

Authors:  Jia Li; Wenting Shang; Yong Li; Sirui Fu; Jie Tian; Ligong Lu
Journal:  Int J Nanomedicine       Date:  2018-10-01

Review 6.  Therapeutic targeting of the hypoxic tumour microenvironment.

Authors:  Dean C Singleton; Andrew Macann; William R Wilson
Journal:  Nat Rev Clin Oncol       Date:  2021-07-29       Impact factor: 66.675

7.  Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.

Authors:  A Rojas; F A Stewart; J Denekamp
Journal:  Br J Cancer       Date:  1983-01       Impact factor: 7.640

8.  A prospective randomised trial of radiation with or without oral and intravesical misonidazole for bladder cancer.

Authors:  R P Abratt; P Craighead; V B Reddi; L A Sarembock
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

9.  Interaction of radiosensitizers and WR-2721. I. Modification of skin radioprotection.

Authors:  A Rojas; F A Stewart; J Denekamp
Journal:  Br J Cancer       Date:  1982-05       Impact factor: 7.640

10.  Quantitative cytochemical assessment of the neurotoxicity of misonidazole in the mouse.

Authors:  C Clarke; K B Dawson; P W Sheldon
Journal:  Br J Cancer       Date:  1982-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.